A Randomized Phase 3 Trial of Sofosbuvir/Velpatasvir/Voxilaprevir for 8 Weeks and Sofosbuvir/Velpatasvir for 12 Weeks for Patients with Genotype 3 HCV Infection and Cirrhosis: The POLARIS-3 Study

被引：0

作者：

Foster, Graham R. ^{[1
]}

Thompson, Alex J. ^{[2
]}

Ruane, Peter J. ^{[3
]}

Borgia, Sergio M. ^{[4
]}

Dore, Gregory ^{[5
]}

Workowski, Kimberly ^{[6
]}

Hyland, Robert H. ^{[7
]}

Wang, Jing ^{[7
]}

Svarovskaia, Evguenia S. ^{[7
]}

Stamm, Luisa M. ^{[7
]}

Brainard, Diana M. ^{[7
]}

Subramanian, Mani ^{[7
]}

McHutchison, John G. ^{[7
]}

Berg, Thomas ^{[8
]}

Agarwal, Kosh ^{[9
]}

Conway, Brian ^{[10
]}

Feld, Jordan J. ^{[11
]}

Willems, Bernard E. ^{[12
]}

Roberts, Stuart K. ^{[13
]}

机构：

[1] Royal London Hosp, London, England

[2] St Vincents Hosp, Dept Gastroenterol, Melbourne, Vic, Australia

[3] Ruane Med & Liver Hlth Inst, Los Angeles, CA USA

[4] William Osler Hlth Syst, Brampton Civ Hosp, Brampton, ON, Canada

[5] St Vincents Publ Hosp, Sydney, NSW, Australia

[6] Emory Univ, Atlanta, GA 30322 USA

[7] Gilead Sci Inc, 353 Lakeside Dr, Foster City, CA 94404 USA

[8] Charite, Med Dept Hepatol & Gastroenterol, Berlin, Germany

[9] Kings Coll Hosp London, Inst Liver Studies, London, England

[10] Vancouver Infect Dis Res & Care Ctr, Vancouver, BC, Canada

[11] Toronto Western Hosp, Ctr Liver, Toronto, ON, Canada

[12] Ctr Hosp Univ Montreal, Montreal, PQ, Canada

[13] Alfred Hosp, Melbourne, Vic, Australia

来源：

关键词：

D O I：

暂无

中图分类号：

R57 [消化系及腹部疾病];

学科分类号：

摘要：

258

引用

页码：135A / 136A

页数：2